Who has invested in Zion Pharma?

Qiming Venture Partners are named among the investors backing Zion Pharma.

Zion Pharma Funding: $69M Raised, Series B (2021)

Zion Pharma funding overview

Zion Pharma is based in Suzhou, China. Zion Pharma has raised $69M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series B announced in April 2021. The round record for Zion Pharma runs through 2021; nothing later has been disclosed. Investors on record include Qiming Venture Partners.

Zion Pharma at a glance

Total raised: $69M
Latest round: Series B
Latest round date: April 2021
Headquarters: Suzhou, China
Notable investors: Qiming Venture Partners

Frequently asked about Zion Pharma funding

How much has Zion Pharma raised?: Zion Pharma has raised $69M in total disclosed funding across the rounds on record.
Who has invested in Zion Pharma?: Qiming Venture Partners are named among the investors backing Zion Pharma.
What was the latest Zion Pharma funding round?: The most recent disclosed round is a Series B, announced in April 2021.
Where is Zion Pharma based?: Zion Pharma is based in Suzhou, China.
When did Zion Pharma last raise?: The last disclosed Zion Pharma round closed in April 2021 at Series B.

Round data for Zion Pharma is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in Suzhou and backer lists below.

Zion Pharma Funding: $69M Raised, Series B (2021)

Zion Pharma funding overview

Zion Pharma at a glance

Frequently asked about Zion Pharma funding

Companies related to Zion Pharma (36)

Browse related funding lists (4)